Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Bionomics Ltd ADR (BNOX)

Bionomics Ltd ADR (BNOX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 4,468
  • Shares Outstanding, K 17,654
  • Annual Sales, $ 0 K
  • Annual Income, $ -15,490 K
  • EBIT $ -9 M
  • EBITDA $ -8 M
  • 60-Month Beta 0.26
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 0.26
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm 0.00
  • Most Recent Earnings N/A on 11/14/24
  • Next Earnings Date 01/01/70
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sector Medical
  • INDUSTRY GROUPING Medical - Biomedical

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/24
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year N/A
  • Growth Rate Est. (year over year) unch

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.2306 +9.76%
on 12/20/24
0.3600 -29.69%
on 12/02/24
-0.0415 (-14.09%)
since 11/22/24
3-Month
0.1770 +42.99%
on 10/28/24
0.6680 -62.11%
on 09/24/24
-0.3642 (-59.00%)
since 09/23/24
52-Week
0.1770 +42.99%
on 10/28/24
1.6000 -84.18%
on 12/28/23
-1.0569 (-80.68%)
since 12/22/23

Most Recent Stories

More News
Bionomics Limited Receives Court Approval for Re-Domiciliation Scheme to Neuphoria Therapeutics Inc.

Bionomics Limited's re-domiciliation scheme to the U.S. has been approved by the Supreme Court of New South Wales.Quiver AI SummaryBionomics Limited has received approval from the Supreme Court of New...

BNOX : 0.2531 (+4.20%)
Bionomics Announces Supreme Court of New South Wales Approves Bionomics’ Re-Domiciliation

BNOX : 0.2531 (+4.20%)
Bionomics Limited Shareholders Approve Re-Domiciliation to the United States with Neuphoria Therapeutics Inc. as New Parent Company

Bionomics shareholders approved the re-domiciliation to the US, pending final court and expert approvals.Quiver AI SummaryBionomics Limited has announced that its shareholders have approved the re-domiciliation...

BNOX : 0.2531 (+4.20%)
Results of Scheme Meeting

BNOX : 0.2531 (+4.20%)
Bionomics Publishes the Positive Results from the Phase 2 ATTUNE Study of BNC210 in Patients with Post-Traumatic Stress Disorder in NEJM Evidence

BNOX : 0.2531 (+4.20%)
Bionomics to Present at the 2024 American College of Neuropsychopharmacology Annual Meeting

BNOX : 0.2531 (+4.20%)
Bionomics Limited Urges Shareholders to Vote for U.S. Re-Domiciliation Proposal

Bionomics urges shareholders to support its re-domiciliation from Australia to the U.S. ahead of upcoming votes.Quiver AI SummaryBionomics Limited, a biotechnology company focused on developing novel treatments...

BNOX : 0.2531 (+4.20%)
Bionomics Reminds Shareholders to Cast their Vote for Re-Domiciliation from Australia to the United States

BNOX : 0.2531 (+4.20%)
Bionomics Provides an Update on Re-domiciliation via Scheme of Arrangement

BNOX : 0.2531 (+4.20%)
Bionomics to Present at the 2024 CNS Summit

BNOX : 0.2531 (+4.20%)

Business Summary

Bionomics Limited is a clinical-stage biopharmaceutical developing novel, allosteric ion channel modulators designed to transform the lives of patients suffering from serious central nervous system disorders. Bionomics Limited is based in ADELAIDE, Australia.

See More

Key Turning Points

3rd Resistance Point 0.3293
2nd Resistance Point 0.3096
1st Resistance Point 0.2814
Last Price 0.2531
1st Support Level 0.2335
2nd Support Level 0.2138
3rd Support Level 0.1856

See More

52-Week High 1.6000
Fibonacci 61.8% 1.0564
Fibonacci 50% 0.8885
Fibonacci 38.2% 0.7206
Last Price 0.2531
52-Week Low 0.1770

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar